Novel Pooling Strategies for Genetic Testing, with Application to Newborn Screening

• Published in: Management science 2022-11, Vol.68 (11), p.7994-8014
• Main Authors: El Hajj, Hussein, Bish, Douglas R., Bish, Ebru K., Kay, Denise M.
• Format: Article
• Language: English
• Subjects: Accuracy; Biological markers; Cystic fibrosis; Decision makers; Deoxyribonucleic acid; DNA; Genetic disorders; Genetic testing; Health status; Life threatening; Medical screening; Newborn babies; newborn screening; Optimization; Partition; partition problem; pooled testing; resource allocation; Variants
• ISSN: 0025-1909; 1526-5501
• DOI: 10.1287/mnsc.2021.4289

Newborn screening (NBS) is a state-level initiative that detects life-threatening genetic disorders for which early treatment can substantially improve health outcomes. Cystic fibrosis (CF) is among the most prevalent disorders in NBS. CF can be caused by a large number of mutation variants to the CFTR gene. Most states use a multitest CF screening process that includes a genetic test ( DNA ). However, due to cost concerns, DNA is used only on a small subset of newborns (based on a low-cost biomarker test with low classification accuracy), and only for a small subset of CF-causing variants. To overcome the cost barriers of expanded genetic testing, we explore a novel approach, of multipanel pooled DNA testing. This approach leads not only to a novel optimization problem (variant selection for screening, variant partition into multipanels, and pool size determination for each panel), but also to novel CF NBS processes. We establish key structural properties of optimal multipanel pooled DNA designs; develop a methodology that generates a family of optimal designs at different costs; and characterize the conditions under which a 1-panel versus a multipanel design is optimal. This methodology can assist decision-makers to design a screening process, considering the cost versus accuracy trade-off. Our case study, based on published CF NBS data from the state of New York, indicates that the multipanel and pooling aspects of genetic testing work synergistically, and the proposed NBS processes have the potential to substantially improve both the efficiency and accuracy of current practices. This paper was accepted by Stefan Scholtes, healthcare management. Funding: This work was supported by National Science Foundation [Grant 1761842]. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. Supplemental Material: The data files and e-companion are available at https://doi.org/10.1287/mnsc.2021.4289 .